A 52-year-old woman with newly diagnosed HER2-positive metastatic breast cancer is being evaluated for targeted therapy with trastuzumab. Which investigation is most appropriate to assess baseline cardiac function before initiating treatment?

See the options, answer & explanation

Sign in free to reveal the answer choices, the correct answer, the detailed explanation, and AI-powered insights for this question.